Research and Markets has announced the addition of the "Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2016" clinical trials to their offering.
The clinical trial report, Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2016" provides an overview of Onchocerciasis (River Blindness) clinical trials scenario. This report provides top line data relating to the clinical trials on Onchocerciasis (River Blindness). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.
The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using Our proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Reasons to buy:
For more information about this clinical trials report visit http://www.researchandmarkets.com/research/fxq5rg/onchocerciasis
View source version on businesswire.com: http://www.businesswire.com/news/home/20161107006167/en/Business Wire
Last updated on: 07/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.